An open-label, multicenter, phase 2a study to assess the feasibility of imaging metastases in late-stage cancer patients with the alpha v beta 3-selective angiogenesis imaging agent 99mTc-NC100692. (Q48382974)
Jump to navigation
Jump to search
scientific article published in February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An open-label, multicenter, phase 2a study to assess the feasibility of imaging metastases in late-stage cancer patients with the alpha v beta 3-selective angiogenesis imaging agent 99mTc-NC100692. |
scientific article published in February 2010 |
Statements
1 reference
An open-label, multicenter, phase 2a study to assess the feasibility of imaging metastases in late-stage cancer patients with the alpha v beta 3-selective angiogenesis imaging agent 99mTc-NC100692. (English)
1 reference
1 reference
Rimma Axelsson
1 reference
Tore Bach-Gansmo
1 reference
Brian J McParland
1 reference
Study Group
1 reference
1 February 2010
1 reference
1 reference
51
1 reference
1
1 reference
40-46
1 reference